Mitra S, Grant C, Nolan S, Mohd Salleh NA, Milloy MJ, Richardson L Assessing the temporality between transitions onto opioid agonist therapy and engagement with antiretroviral therapy in a cohort of HIV-positive people who use opioids daily AIDS Behav, 2022. PubMed

Reddon H, Socías ME, Justice A, Cui Z, Nosova E, Barrios R, Fairbairn N, Marshall BDL, Milloy MJ Periods of homelessness linked to higher VACS index among HIV-positive people who use drugs AIDS Behav, 2022. PubMed

Pilarinos A, Fast D, Nosova E, Kwa Y, Joe R, Buxton J, DeBeck K Initiation of opioid agonist treatment and subsequent substance use and other patterns among adolescents and young adults in Vancouver, Canada Drug Alcohol Depend, 2022. PubMed

Moshkforoush M, DeBeck K, Brar R, Fairbairn N, Cui Z, Milloy MJ, Buxton J, Oldenburger T, McLellan W, Kendall P, Sedgemore K, Wilson D, Kerr T, Hayashi K Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada Harm Reduct J, 2022. PubMed

Juwono S, Milloy MJ, Choi JC, Fairbairn N, Nolan S, Socías ME Opioid agonist treatment improves progression through the HIV cascade of care among people living with HIV who use unregulated opioids AIDS, 2022. PubMed

Meyers-Pantele S, Mittal M, Jain S, Sun S, Rammohan I, Fairbairn N, Milloy MJ, DeBeck K, Hayashi K, Werb D The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance Subst Abuse Treat Prev Policy, 2022. PubMed

Klaire S, Sutherland C, Kerr T, Kennedy MC A low-barrier, flexible safe supply program to prevent deaths from overdose CMAJ, 2022. PubMed

Canêdo J, Sedgemore K, Ebbert K, Anderson H, Dykeman R, Kinkaid K, Dias C, Silva D, Youth Health Advisory Council, Charlesworth R, Knight R, Fast D Harm reduction calls to action from young people who use drugs on the streets of Vancouver and Lisbon Harm Reduct J, 2022. PubMed

Weng J, Fairbairn N, Sutherland C, Johnson C, Nolan S Supervised Tablet injectable Opioid Agonist Therapy (TiOAT): a strategy to address safer supply for individuals with an opioid use disorder? J Addict Med, 2022. PubMed

Xu K, Nolan S, Mihic T, Ti L Improving opioid stewardship programs through shared decision-making J Am Pharm Assoc, 2022. PubMed